Detalhe da pesquisa
1.
MAFF confers vulnerability to cisplatin-based and ionizing radiation treatments by modulating ferroptosis and cell cycle progression in lung adenocarcinoma.
Drug Resist Updat
; 73: 101057, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38266355
2.
Inhibition of PKA/CREB1 pathway confers sensitivity to ferroptosis in non-small cell lung cancer.
Respir Res
; 24(1): 277, 2023 Nov 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37957645
3.
AGRN promotes lung adenocarcinoma progression by activating Notch signaling pathway and acts as a therapeutic target.
Pharmacol Res
; 194: 106819, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37321467
4.
Metformin inhibits human non-small cell lung cancer by regulating AMPK-CEBPB-PDL1 signaling pathway.
Cancer Immunol Immunother
; 71(7): 1733-1746, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34837101
5.
Cisplatin resistance-related multi-omics differences and the establishment of machine learning models.
J Transl Med
; 20(1): 171, 2022 04 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35410350
6.
Multi-omics characterization and validation of invasiveness-related molecular features across multiple cancer types.
J Transl Med
; 19(1): 124, 2021 03 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33766047
7.
Pan-cancer characterization of metabolism-related biomarkers identifies potential therapeutic targets.
J Transl Med
; 19(1): 219, 2021 05 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34030708
8.
Knockdown of GTF2E2 inhibits the growth and progression of lung adenocarcinoma via RPS4X in vitro and in vivo.
Cancer Cell Int
; 21(1): 181, 2021 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33757492
9.
Identification and validation of tumor environment phenotypes in lung adenocarcinoma by integrative genome-scale analysis.
Cancer Immunol Immunother
; 69(7): 1293-1305, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32189030
10.
Retinoic acid receptor alpha inhibits ferroptosis by promoting thioredoxin and protein phosphatase 1F in lung adenocarcinoma.
Commun Biol
; 7(1): 751, 2024 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38902322
11.
Transcription factor ZNF263 enhances EGFR-targeted therapeutic response and reduces residual disease in lung adenocarcinoma.
Cell Rep
; 43(2): 113771, 2024 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38335093
12.
Polyamine-mediated ferroptosis amplification acts as a targetable vulnerability in cancer.
Nat Commun
; 15(1): 2461, 2024 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38504107
13.
The immunomodulatory role of all-trans retinoic acid in tumor microenvironment.
Clin Exp Med
; 23(3): 591-606, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35829844
14.
Hepatic nuclear factor 4 alpha promotes the ferroptosis of lung adenocarcinoma via transcriptional activation of cytochrome P450 oxidoreductase.
PeerJ
; 11: e15377, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37180584
15.
PLK1 regulating chemoradiotherapy sensitivity of esophageal squamous cell carcinoma through pentose phosphate pathway/ferroptosis.
Biomed Pharmacother
; 168: 115711, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37879213
16.
Characterization of Infiltrating Immune Cells and Secretory or Membrane-Associated Proteins in KRAS Lung Adenocarcinoma.
J Immunol Res
; 2023: 4987832, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36793588
17.
HNF4G increases cisplatin resistance in lung adenocarcinoma via the MAPK6/Akt pathway.
PeerJ
; 11: e14996, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36923501
18.
Identification of the relationship between single-cell N6-methyladenosine regulators and the infiltrating immune cells in esophageal carcinoma.
Heliyon
; 9(8): e18132, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37529341
19.
KLF11 regulates lung adenocarcinoma ferroptosis and chemosensitivity by suppressing GPX4.
Commun Biol
; 6(1): 570, 2023 05 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37248295
20.
Retinol Saturase Mediates Retinoid Metabolism to Impair a Ferroptosis Defense System in Cancer Cells.
Cancer Res
; 83(14): 2387-2404, 2023 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37184371